The journal welcomes submissions across — but not limited to — the following areas:

• Cerebrovascular disease, stroke, and neurovascular intervention
• Neurodegenerative disorders: Alzheimer's, Parkinson's, ALS, and related conditions
• Neuro-oncology, brain tumours, and surgical neuroradiology
• Epilepsy, seizure disorders, and electrophysiology
• Neuroimaging: MRI, fMRI, PET, and advanced imaging biomarkers
• Cognitive neuroscience, neuropsychology, and dementia
• Spine, peripheral nerve, and neuromuscular disease
• Neuroinflammation, neuroimmunology, and multiple sclerosis
• Paediatric neurology and developmental brain disorders

• Original Research — Empirical studies reporting novel findings
• Systematic Review & Meta-Analysis — Rigorous synthesis of existing evidence
• Clinical Case Report — Instructive cases with clear educational value
• Perspective & Commentary — Expert views on emerging topics or policy issues
• Methods & Technology — Novel techniques, devices, or tools with validation
• Editorial — Invited commentary from the editorial board

All submissions undergo single-anonymous peer review conducted by at least two independent domain experts. The editorial board is committed to transparent, constructive, and timely review.

Brain Conflux adheres to COPE (Committee on Publication Ethics) guidelines and requires all clinical research to comply with applicable ethical standards and reporting guidelines (CONSORT, STROBE, PRISMA, CARE, etc.).